A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants
Trial details
- Registry ID
- NCT04903288
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric ParticipantsNCT04903288 | PTC Therapeutics | Phase 2 | Active not recruiting | 2023-05-22Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |